Vegan Thrive, A Capsule-in-Capsule Supplement for Vegans

  • Robert from Robert DiSilvestro
  • From United States
  • Responsive
  • Investment Opportunities in Startups and Spinoffs

Summary of the technology

Vegans comprise a large niche market for nutritional supplements. These consumers generally take supplements, but no one product has conquered the market. A new product can now be produced that
Features superior nutrition compared to existing products;
Is formulated based on clinical research and market surveys of consumer wants;
Uses a high tech capsule delivery system that gives composition and aesthetic advantages;
And which can be publicized by a great business team.

A request is made for $49,500 investment to start the sales process.

Robert DiSilvestro

Details of the Technology Offer

Most of the nearly 10 million US vegans recognize a need for nutrient supplementation. Moreover, the vegan supplement market was predicted to show a compound annual growth rate (CAGR) of 7.75 percent from 2021 to 2026. Yet, based on social media monitoring, the formulator’s own on line market surveys (including a recent one), and a Modor Intelligence report, no current supplement dominates the market. A new product is proposed that features superior nutrition, a high tech capsule delivery system, and a great business team. The nutritional content is based on published research data (including some from the formulator). The supplement nutrient composition differs from other vegan supplements in the following ways:

  • Includes some nutrients left out of other vegan supplements; this includes vitamin K2, which was rated as highly wanted in the formulator’s last market survey;
  • Uses versions of certain nutrients that have specific advantages;
  • Uses advanced capsule technologies to get relatively high amounts of algae omega-3-fatty acids into 2 capsules (fatty acids that are the vegan version of fish oil);
  • Is delivered by a capsule in capsule; this technology allows mixing the omega-3 fatty acid oil with nutrients that don’t normally mix well with oil; this capsule in capsule approach also gives a visual high tech look that can appeal to consumers;
  • Omits filler nutrients most vegans don’t need in a supplement (a creditability producer);
  • Unlike some competitors, avoids high doses of vitamins D and B12 that can cause harm.

The face of the product will be the highly visible vegan dietitian and author Sharon Palmer (who will hold some company equity). Also, a young social media marketer, who is a vegan, will moonlight to lead influencer social media engagement. In addition, the company will include a marketer with a track record of building large social media followings. Also, business supervision will be provided by Neil Collins, MBA Harvard. Neil has worked for big companies like Borden, but also runs Innovate New Albany, an entrepreneurial startup business center.

Interest from the target customer base has been verified by great results in online market surveys and professional in person interviews. Duplication of the product by other companies will be hindered by a provisional patent, an exclusive arrangement with a key ingredient supplier, and an exclusivity policy of the delivery system producer. In summary, a strong team will sell a protected product geared to a substantial and growing market with interest in this product.

Intellectual property status

A provisional patent is about to be submitted. Also, an exclusivity aggreement for vegan supplements will happen with a key ingredient supplier. In addition, exclusivity for the formulation will occur with the producer of the high tech capsule needed for this product.

Related Keywords

  • Agriculture and Marine Resources
  • Agrofood Industry
  • Medical Health related
  • Other Medical/Health Related
  • Other medical/health related (not elsewhere classified)
  • Consumer related
  • Consumer Products
  • Health and beautty aids, Cosmetics
  • Other
  • vegan

About Me

Biographical Sketch, Dr. Robert DiSilvestro

Dr. DiSilvestro holds a PhD in biochemistry from Texas A&M University, was a nutrition professor for 34 years, and is currently Professor Emeritus of Human Nutrition at The Ohio State University. His research has spanned diverse topics from basic physiology and biochemistry to human intervention studies (which include “non-wet lab” measures in people). This professor has authored/co-authored close to 110 peer reviewed research journal articles, written a number of reviews, composed book chapters, and written a whole book on the state of research for mineral supplements. Dr. DiSilvestro has been on editorial boards for a number of research journals and has been a reviewer for various grant programs (including one for nutrition research with business potential). He has also spoken at a number of nutrition industry trade shows and written for nutrition industry trade journals. He also has done consulting for food and supplement industries (ie. Pepsico, Dupont, and Bausch & Lomb). He also currently runs two startup companies.

Research Accomplishments, Dr. Robert DiSilvestro

My early research emphasized metalloprotein biochemistry and physiology. Some of that work was on copper and zinc transport, which helped set the stage for later explosions in chaperone research. I also developed some metalloenzyme methodology, and was the first to show that moderate mineral deficiencies affect certain metalloenzyme activities. Further work clarified conflicting data on the molecular weight of superoxide dismutase3. Early work also demonstrated that a green tea flavonoid can affect copper enzyme metabolism. At the time, flavonoid bioactivity research was almost nonexistent (a situation that has changed). My mineral work then shifted to applied human nutrition such as finding how to assess marginal deficiencies. The work also compared bioactivities for different versions of minerals. In addition, some consequences of marginal mineral deficiencies were characterized including effects on ADHD children (one article was a cover story for a journal issue).

Eventually, this researcher expanded into nonmineral nutrients and nutraceuticals. Some work examined how well one supplement version fared versus others. In another area, one paper demonstrated that the herb kava was not hepatotoxic. This spawned studies by others that led a European regulatory body reversing a position on kava hepatotoxicity. In other work, a study was done on protein and exercise-induced muscle gain. The resulting paper was the most online accessed research article for the journal for a long time. In a related direction, a series of studies were done on soy products, including one that debunked the idea that they lower testosterone readings in men. Other research showed that by simply eating one apple a day, profound effects are produced for a measure related to heart disease risk. This received wide media coverage.

In various projects, side measures were taken and the data stored. This remains a way to jump start future research. In one case, some natural/semi-natural ingredients were noted to lower triglyceride readings. Three of them are hypothesized to act additively or synergistically.

Robert DiSilvestro

Never miss an update from Robert DiSilvestro

Create your free account to connect with Robert DiSilvestro and thousands of other innovative organizations and professionals worldwide

Robert

Send a request for information
to Robert

About Technology Offers

Technology Offers on Innoget are directly posted
and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.

Help

Need help requesting additional information or have questions regarding this Technology Offer?
Contact Innoget support